MK-0893
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MK-0893, covering 2014-03-18 to 2015-08-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study of MK-0893 on Glucagon-Induced Glycemic Excursion in Healthy Male Participants Following Intravenous Administration of Glucagon, Sandostatine® and Insulin (MK-0893-002) [Phase 1]